Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells

Fiza Singh, Dayuan Gao, Mark G. Lebwohl, Huachen Wei

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

Shikonin isolated from the roots of the Chinese herb Lithospermum erythrorhizon has been associated with anti-inflammatory properties. We evaluated shikonin's chemotherapeutic potential and investigated its possible mechanism of action in a human cutaneous neoplasm in tissue culture. Shikonin preferentially inhibits the growth of human epidermoid carcinoma cells concentration- and time-dependently compared to SV-40 transfected keratinocytes, demonstrating its anti-proliferative effects against this cancer cell line. Additionally, shikonin decreased phosphorylated levels of EGFR, ERK1/2 and protein tyrosine kinases, while increasing phosphorylated JNK1/2 levels. Overall, shikonin treatment was associated with increased intracellular levels of phosphorylated apoptosis-related proteins, and decreased levels of proteins associated with proliferation in human epidermoid carcinoma cells.

Original languageEnglish
Pages (from-to)115-121
Number of pages7
JournalCancer Letters
Volume200
Issue number2
DOIs
StatePublished - 28 Oct 2003

Keywords

  • Epidermal growth factor receptor
  • Human epidermoid carcinoma cells
  • Protein tyrosine kinase
  • Shikonin
  • c-jun N-terminal kinase

Fingerprint

Dive into the research topics of 'Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells'. Together they form a unique fingerprint.

Cite this